Blog
Form 8.3 - Apex Fundrock Limited : Re Tyman plc
Form 8.3 - Apex Fundrock Limited : Re Tyman plc
EQS-News: Nabaltec AG: Annual General Meeting once again resolves to distribute a dividend of EUR 0.28 per share
EQS-News: Nabaltec AG: Annual General Meeting once again resolves to distribute a dividend of EUR 0.28 per share
Dalata Hotel Group PLC: HOL-Holding(s) in Company*
Dalata Hotel Group PLC: HOL-Holding(s) in Company*
EQS-News: Eckert & Ziegler Subsidiary Pentixapharm Receives Encouraging FDA Feedback to Initiate Phase III Trial with PentixaFor as Radiopharmaceutical Diagnostic in Primary Aldosteronism
EQS-News: Eckert & Ziegler Subsidiary Pentixapharm Receives Encouraging FDA Feedback to Initiate Phase III Trial with PentixaFor as Radiopharmaceutical Diagnostic in Primary Aldosteronism
Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Initial Sale Prices
Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Initial Sale Prices
EQS-News: ElringKlinger to open new Battery Center in the USA
EQS-News: ElringKlinger to open new Battery Center in the USA
Britvic plc Share Repurchase Programme Suspension
Britvic plc Share Repurchase Programme Suspension
EQS-News: Date set for Annual General Meeting
EQS-News: Date set for Annual General Meeting
Edison issues report on Metlen Energy & Metals (MYTIL)
Edison issues report on Metlen Energy & Metals (MYTIL)
EQS-News: Branicks Group AG: New and follow-up lettings in Frankfurt's trade fair and banking district
EQS-News: Branicks Group AG: New and follow-up lettings in Frankfurt's trade fair and banking district
EQS-News: clearvise AG realizes two more solar parks through cooperation in Italy
EQS-News: clearvise AG realizes two more solar parks through cooperation in Italy
EQS-News: DEFENCE’S ARM-X ANTI-CANCER VACCINE INHIBITS GROWTH OF PRE-ESTABLISHED OVARIAN CANCER RESULTING IN COMPLETE RESPONSES IN TREATED ANIMALS
EQS-News: DEFENCE’S ARM-X ANTI-CANCER VACCINE INHIBITS GROWTH OF PRE-ESTABLISHED OVARIAN CANCER RESULTING IN COMPLETE RESPONSES IN TREATED ANIMALS
Agreement reached with iBusiness Funding to acquire Funding Circle’s US business
Agreement reached with iBusiness Funding to acquire Funding Circle’s US business
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Solidcore Resources plc: MOEX delisting application
Solidcore Resources plc: MOEX delisting application
EQS-News: Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
EQS-News: Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
EQS-News: HORNBACH Group delivers strong Q1 2024/25 results increasing earnings per share y-o-y by 44% – full-year outlook confirmed unchanged
EQS-News: HORNBACH Group delivers strong Q1 2024/25 results increasing earnings per share y-o-y by 44% – full-year outlook confirmed unchanged
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
Meyer Burger makes significant progress in relocating its core business to the USA
Meyer Burger makes significant progress in relocating its core business to the USA
EQS-News: BIRKENSTOCK ANNOUNCES LAUNCH OF SECONDARY OFFERING
EQS-News: BIRKENSTOCK ANNOUNCES LAUNCH OF SECONDARY OFFERING
EQS-News: CureVac Announces Voting Results of General Meeting
EQS-News: CureVac Announces Voting Results of General Meeting
EQS-Adhoc: VIB Vermögen AG: Amount of cash compensation for merger squeeze-out at BBI Bürgerliches Brauhaus Immobilien Aktiengesellschaft set at EUR 14.96 per share
EQS-Adhoc: VIB Vermögen AG: Amount of cash compensation for merger squeeze-out at BBI Bürgerliches Brauhaus Immobilien Aktiengesellschaft set at EUR 14.96 per share
EQS-Adhoc: Airbus provides 2024 guidance update
EQS-Adhoc: Airbus provides 2024 guidance update
EQS-News: CPI PROPERTY GROUP – Update on Poland Equity Investment
EQS-News: CPI PROPERTY GROUP – Update on Poland Equity Investment
EQS-Adhoc: Merck KGaA: Phase III trials of xevinapant in locally advanced head & neck cancer discontinued
EQS-Adhoc: Merck KGaA: Phase III trials of xevinapant in locally advanced head & neck cancer discontinued


